UB Paderborn / Katalog / Suche / in CDI

Risk of Arterial Thrombotic Events in Inflammatory Bowel Disease

The American journal of gastroenterology, 2009-06, Vol.104 (6), p.1445-1451

2009

Link zum Volltext

Verfügbarkeit prüfen

Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease‐Modifying Antirheumatic Drugs

Arthritis & rheumatology (Hoboken, N.J.), 2016-01, Vol.68 (1), p.67-76

2016

Link zum Volltext

Verfügbarkeit prüfen

OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results

Journal of the American Academy of Dermatology, 2015-01, Vol.72 (1), p.115-122

2015

Link zum Volltext

Verfügbarkeit prüfen

Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis

Arthritis research & therapy, 2020-10, Vol.22 (1), p.1-253, Article 253

2020

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis

Arthritis care & research (2010), 2017-10, Vol.69 (10), p.1510-1518

2017

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231182386-17588359231182386

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines

Annals of surgical oncology, 2007-06, Vol.14 (6), p.1924-1933

2007

Link zum Volltext

Verfügbarkeit prüfen

Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity

Arthritis research & therapy, 2017-05, Vol.19 (1), p.86-86, Article 86

2017

Link zum Volltext

Verfügbarkeit prüfen

Distribution of Health Care Expenditures for HIV-Infected Patients

Clinical infectious diseases, 2006-04, Vol.42 (7), p.1003-1010

2006

Link zum Volltext

Verfügbarkeit prüfen

Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry

ACR open rheumatology, 2020-10, Vol.2 (10), p.588-594

2020

Link zum Volltext

Verfügbarkeit prüfen

A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population

Pediatric dermatology, 2019-05, Vol.36 (3), p.290-297

2019

Link zum Volltext

Verfügbarkeit prüfen

Trends in AIDS-Defining and Non—AIDS-Defining Malignancies among HIV-Infected Patients: 1989–2002

Clinical infectious diseases, 2004-11, Vol.39 (9), p.1380-1384

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis

Arthritis care & research (2010), 2018-05, Vol.70 (5), p.679-684

2018

Link zum Volltext

Verfügbarkeit prüfen

Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease‐Modifying Antirheumatic Drug Treatment

Arthritis care & research (2010), 2019-04, Vol.71 (4), p.512-520

2019

Link zum Volltext

Verfügbarkeit prüfen

Potential for Major Therapeutic Changes to Produce Significant Clinical Response Across a Broad Range of Disease Activity: An Observational Study of US Veterans With Rheumatoid Arthritis

Arthritis care & research (2010), 2021-07, Vol.73 (7), p.964-974

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer

Future oncology (London, England), 2021-12, Vol.17 (36), p.5119

2021

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use

Pharmacoepidemiology and drug safety, 2017-09, Vol.26 (9), p.1109-1118

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapy with Biologic Agents After Diagnosis of Solid Malignancies: Results from the Corrona Registry

Journal of rheumatology, 2019-11, Vol.46 (11), p.1438

2019

Link zum Volltext

Verfügbarkeit prüfen

Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis

Rheumatology international, 2017-07, Vol.37 (7), p.1075-1082

2017

Link zum Volltext

Verfügbarkeit prüfen

Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry

Journal of rheumatology, 2017-02, Vol.44 (2), p.184

2017

Link zum Volltext

Verfügbarkeit prüfen

Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis

Advances in therapy, 2017-09, Vol.34 (9), p.2093-2103

2017

Link zum Volltext

Verfügbarkeit prüfen

Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting

Rheumatology international, 2019-09, Vol.39 (9), p.1547-1558

2019

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance

Journal of managed care & specialty pharmacy, 2020-04, Vol.26 (4), p.417

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma

Annals of surgical oncology, 2008-05, Vol.15 (5), p.1476-1484

2008

Link zum Volltext

Verfügbarkeit prüfen

Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation

Annals of internal medicine, 2006-05, Vol.144 (10), p.735

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Risk of Arterial Thrombotic Events in Inflammatory Bowel Disease

Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease‐Modifying Antirheumatic Drugs

OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results

Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis

Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines

Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity

Distribution of Health Care Expenditures for HIV-Infected Patients

Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry

A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population

Trends in AIDS-Defining and Non—AIDS-Defining Malignancies among HIV-Infected Patients: 1989–2002

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis

Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease‐Modifying Antirheumatic Drug Treatment

Potential for Major Therapeutic Changes to Produce Significant Clinical Response Across a Broad Range of Disease Activity: An Observational Study of US Veterans With Rheumatoid Arthritis

Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer

Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use

Therapy with Biologic Agents After Diagnosis of Solid Malignancies: Results from the Corrona Registry

Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis

Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry

Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis

Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance

Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma

Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation

Suchergebnisse filtern